Madhya Pradesh SIT inter-state investigation into spurious cough syrup
Source:The Hindu ↗
Why It Matters
The manufacture of substandard or adulterated drugs in one state and their distribution nationwide poses a major public health risk. It tests the efficacy of India's fragmented drug regulatory architecture (shared between CDSCO and State Drug Controllers) and brings focus to the legal and logistical challenges of inter-state police investigations.
Summary
A Special Investigation Team (SIT) from Madhya Pradesh launched an inter-state probe at the registered address of a cough syrup manufacturer in Tamil Nadu. The investigation stems from health concerns associated with the pharmaceutical company's products distributed across state lines. The incident underscores significant public health and governance challenges, particularly regarding the regulation of pharmaceutical manufacturing, the monitoring of drug safety, and the crucial need for seamless inter-state coordination among law enforcement and health regulatory bodies to curb the menace of substandard or spurious drugs.
Key Points
- A Special Investigation Team (SIT) from Madhya Pradesh conducted an investigation at the registered address of a cough syrup manufacturer located in Tamil Nadu.
- The probe follows concerns related to the quality or effects of the cough syrup produced by the manufacturer, which had inter-state distribution.
- This incident highlights the administrative and regulatory challenges involving pharmaceutical manufacturing, cross-border distribution, and quality control of drugs in India.
- It underlines the necessity for better coordination between State Police and State Drug Controllers to quickly act on public health threats caused by spurious or substandard drugs.
Important Terms
Central Drugs Standard Control Organisation (CDSCO)
India's national regulatory body for pharmaceuticals, medical devices, and cosmetics. Under the Ministry of Health, it ensures drug safety, efficacy, and quality through national standards and approvals.
UPSC context
GS Paper II (Regulatory Bodies) and Paper III (Health); tests understanding of pharmaceutical governance and national standards.
Drugs and Cosmetics Act, 1940
The central legislation governing the import, manufacture, distribution, and sale of drugs and cosmetics in India. It aims to prevent substandard, misbranded, or spurious products from reaching consumers.
UPSC context
GS Paper II (Statutory Provisions); essential for questions on healthcare laws and regulatory frameworks in India.
Special Investigation Team (SIT)
A temporary, specialized unit of law enforcement officers or experts appointed by the government or judiciary to investigate high-profile, complex, or serious criminal cases.
UPSC context
GS Paper II (Governance/Criminal Justice System); relevant for probes into systemic failures or inter-state crimes.
Drugs Controller General of India (DCGI)
The statutory head of the CDSCO who serves as the apex authority for approving new drugs and clinical trials, and licensing critical products like vaccines.
UPSC context
GS Paper II (Statutory Bodies); key position tested regarding health sector leadership and drug approval processes.
State Drugs Control Departments
State-level statutory authorities responsible for granting manufacturing and sale licenses, conducting inspections of pharma units, and enforcing the Drugs and Cosmetics Act within their jurisdiction.
UPSC context
GS Paper II (Federalism and Centre-State Relations); tests knowledge of the dual-regulatory structure in India's health sector.
Prelims Trap
"The Central Drugs Standard Control Organisation (CDSCO) is the sole authority granting manufacturing licenses for all drugs."
Under the Drugs and Cosmetics Act, 1940, CDSCO approves new drugs, but State Drug Controllers issue manufacturing and sales licenses.
Static Concepts Connected
How is drug regulation structurally divided between the Centre and States in India?
- CDSCO (Centre): Responsible for approving new drugs, regulating clinical trials, and controlling the quality of imported pharmaceuticals.
- State Drug Controllers: Empowered to grant licenses for the manufacturing, sale, and intra-state distribution of drugs.
- Statutory Basis: The dual regulatory framework is established under the Drugs and Cosmetics Act, 1940, leading to fragmented oversight.
What causes the fatal toxicity associated with contaminated cough syrups?
- Toxic Adulterants: Diethylene Glycol (DEG) and Ethylene Glycol (EG) are illegally used as cheap industrial substitutes for safe solvents like propylene glycol.
- Physiological Impact: Ingestion of these chemicals severely damages the kidneys, causing acute renal failure, neurological toxicity, and death.
Cross-Topic Patterns
Spurious Drugs & India's Export Soft Power
Domestic regulatory failures (e.g., DEG contamination) directly impact India's 'Pharmacy of the World' soft power, prompting the DGFT to mandate mandatory pre-export testing for cough syrups.
Federalism in Law Enforcement Jurisdiction
A State SIT operating in another state relies on CrPC/BNSS provisions for inter-state pursuit, highlighting cooperative federalism in law enforcement outside central agencies like the CBI.
A multi-statement question contrasting CDSCO's new drug approvals with States' manufacturing licensing powers is highly likely in 2026.
Linked PYQs · 3
Linked PYQs · 3
- 2021MainsGS2
The jurisdiction of the Central Bureau of Investigation (CBI) regarding lodging an FIR and conducting probe within a particular State is being questioned by various States. However, the power of the States to withhold consent to the CBI is not absolute. Explain with special reference to the federal character of India.
- 2024MainsGS2
In a crucial domain like the public healthcare system the Indian State should play a vital role to contain the adverse impact of marketisation of the system. Suggest some measures through which the State can enhance the reach of public healthcare at the grassroots level.
- 2015MainsGS2
Public health system has limitations in providing universal health coverage. Do you think that the private sector could help in bridging the gap? What other viable alternatives would you suggest?
